Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Cymabay Therapeutics Inc. (CBAY)

« Back to company index

CBAY Chatter Timeline

Stock Ticker for CBAY

Most Active Tweeters for CBAY

UserTweets
@PersimmonTI 10
@Tickeron 7
@HealthcareBeat 4
@WeekHerald 3
@OlympiaReport 3

Recent Tweets for CBAY

TJsProtrades @TJsProtrades
$CBAY $SONN again moving
July 15th 2020, 5:07pm
jaga_zoom @jaga_zoom
$CBAY awaking +7%
July 15th 2020, 10:07am
W170Ro @W170Ro
$cbay find it hard to believe that cantor would back this company without knowing FDA outcome, bet they have knowle… https://t.co/x284bL8oKP
July 15th 2020, 10:07am
HealthcareBeat @HealthcareBeat
Form 424B5 (prospectus [rule 424(b)(5)]) filed with the SEC $CBAY https://t.co/VCnke666rl
July 15th 2020, 3:07am
HealthcareBeat @HealthcareBeat
Form 424B5 (prospectus [rule 424(b)(5)]) filed with the SEC $CBAY https://t.co/fBWHHLiAQD
July 15th 2020, 3:07am
WeekHerald @WeekHerald
CymaBay Therapeutics $CBAY Cut to “Sell” at Zacks Investment Research https://t.co/BhLPFsRewI
July 14th 2020, 6:07pm
SEC_Filings_Now @SEC_Filings_Now
$CBAY: New SEC Filing for $CBAY: Form 424B5 (No. 0001193125-20-192617): https://t.co/LbnztKJOKD
July 14th 2020, 4:07pm
SEC_Filings_Now @SEC_Filings_Now
$CBAY: New SEC Filing for $CBAY: Form 424B5 (No. 0001193125-20-192616): https://t.co/jYvnOnGkOL
July 14th 2020, 4:07pm
FlashAlert_me @FlashAlert_me
$CBAY [15s. delayed] filed form 424B5 on July 14, 16:13:25 https://t.co/fMurfNvFgX
July 14th 2020, 4:07pm
fintel_io @fintel_io
$CBAY / Cymabay Therapeutics files form 424B5 https://t.co/WbMr37YFLV
July 14th 2020, 4:07pm
FlashAlert_me @FlashAlert_me
$CBAY [15s. delayed] filed form 424B5 on July 14, 16:12:26 https://t.co/nnxSjCsYUI
July 14th 2020, 4:07pm
FlashAlert_me @FlashAlert_me
$CBAY [15s. delayed] filed form EFFECT on July 14, 00:15:22 https://t.co/5MQDpS16pX
July 14th 2020, 6:07am
EdgarInsider @EdgarInsider
A Form EFFECT filing has been made with the SEC: $CBAY #CymaBayTherapeutics, Inc https://t.co/M7GooIuK0c
July 14th 2020, 6:07am
tradersreport @tradersreport
RT @Tickeron: $CBAY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on June 23, 2020. View odds for this and other ind…
July 14th 2020, 4:07am
Tickeron @Tickeron
$CBAY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on June 23, 2020. View odds for this and… https://t.co/Q1xEi2zHfV
July 14th 2020, 4:07am
Tickeron @Tickeron
$CBAY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on June 23, 2020. View odds for this a… https://t.co/sC2AvULdvM
July 12th 2020, 3:07am
Tickeron @Tickeron
$CBAY's Aroon indicator drops into Downtrend on June 22, 2020. View odds for this and other indicators:… https://t.co/Hlzjq4KjVX
July 11th 2020, 3:07am
SwingTradeBot @SwingTradeBot
Rose Above 50 DMA today: $CBAY ... https://t.co/qwiJH6vr1O
July 10th 2020, 12:07pm
EnterpriseLeade @EnterpriseLeade
CymaBay Therapeutics Inc $CBAY Short Interest Down 8.7% in June https://t.co/vt88DxE772
July 10th 2020, 6:07am
WeekHerald @WeekHerald
Zacks: Brokerages Expect CymaBay Therapeutics Inc $CBAY to Announce -$0.24 Earnings Per Share https://t.co/c7gZQpUj7N
July 9th 2020, 1:07pm
OlympiaReport @OlympiaReport
Brokerages Expect CymaBay Therapeutics Inc $CBAY Will Post Earnings of -$0.24 Per Share https://t.co/8QIIeEwfeE
July 9th 2020, 1:07pm
Tickeron @Tickeron
$CBAY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on June 23, 2020. View odds for this and… https://t.co/tY5KcrTmCP
July 9th 2020, 5:07am
OlympiaReport @OlympiaReport
CymaBay Therapeutics Inc $CBAY Short Interest Update https://t.co/nSMlYfUbgm
July 8th 2020, 3:07pm
AmericanBanking @AmericanBanking
CymaBay Therapeutics Inc $CBAY Short Interest Update https://t.co/JLxzHSOAUU #stocks
July 8th 2020, 3:07pm
erinconsulting @erinconsulting
$CBAY FDA will lift on hold of NASH treatment Phase 2b study of Seladelpar. Should happen anytime now. It's been a… https://t.co/kl1YMfhsF7
July 8th 2020, 8:07am
ConsumerFeed @ConsumerFeed
-$0.24 EPS Expected for CymaBay Therapeutics Inc $CBAY This Quarter https://t.co/BMvOLSKrOc
July 7th 2020, 10:07am
InvestorsLivee @InvestorsLivee
RT @InvestorsLive: Very close here $CBAY
July 7th 2020, 9:07am
kylewxdennis @kylewxdennis
RT @kylewdennis: Had a really nice short term play on $CBAY today. Nice company, chart, and catalyst. Timed the market bounce here today ni…
July 6th 2020, 8:07am
kylewxdennis @kylewxdennis
RT @kylewdennis: Locking in about $2,400 on $CBAY on just a 1 day hold. Nice overall market bounce today. What a way to close out the month…
July 6th 2020, 8:07am
MaisaCorp @MaisaCorp
$CBAY S-3 $200M
July 6th 2020, 7:07am
EnterpriseLeade @EnterpriseLeade
CymaBay Therapeutics Inc $CBAY Expected to Announce Earnings of -$0.24 Per Share https://t.co/6u9lzJlsvb
July 5th 2020, 6:07am
OlympiaReport @OlympiaReport
Brokerages Set CymaBay Therapeutics Inc $CBAY Target Price at $9.20 https://t.co/5YZefFPpcE
July 4th 2020, 8:07pm
WeekHerald @WeekHerald
Brokerages Set CymaBay Therapeutics Inc $CBAY Target Price at $9.20 https://t.co/G10EmWQhgd
July 4th 2020, 8:07pm
Tickeron @Tickeron
$CBAY enters a Downtrend because Momentum Indicator dropped below the 0 level on June 29, 2020. View odds for this… https://t.co/Z1QKk30Qlc
July 4th 2020, 6:07am
PersimmonTI @PersimmonTI
$ICPT $CBAY Ultimately, re-initiation of seladelpar clinical development (in PBC & NASH fibrosis) will depend on… https://t.co/mXZd8tLB6X
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$ICPT $CBAY Though OCA approved & commercially available for PBC, a not uncommon side effect is pruritis (itchines… https://t.co/cO1E3o8MQN
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$ICPT $CBAY "FDA has progressively increased complexity of histologic endpoints, creating very high bar that only… https://t.co/GoC3vmwe4o
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$ICPT $CBAY So, perhaps not all that surprising that FDA decided against AA for OCA in NASH fibrosis, choosing in… https://t.co/k3gBdG9reA
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$ICPT $CBAY Though no OCA liver damage safety signals in NASH yet, long-term effects unknown. Perhaps more worris… https://t.co/ujPSTNN2lH
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$CBAY $ICPT (Over)dosage-related liver damage, which necessitated black box label for OCA's approved indication,… https://t.co/BkcuY8wUyg
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$CBAY $ICPT And, as to safety: 2) Potential Risks Starting with just REGENERATE: Pruritis (itchiness) -- -… https://t.co/kt7yjcU9V2
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$CBAY $ICPT Many moving pieces here; let's try put some of that puzzle together. Doubtless, the FDA's CRL for… https://t.co/vXPZmyWntx
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$CBAY $ICPT Taking these in turn: 1) Uncertain benefit from OCA based on surrogate histopathologic endpoint:… https://t.co/qOM5HOK0i4
July 3rd 2020, 4:07pm
PersimmonTI @PersimmonTI
$CBAY $ICPT endpoint remains uncertain and does not sufficiently outweigh the potential risks to support accelerat… https://t.co/nMiHnA7U8d
July 3rd 2020, 4:07pm
HealthcareBeat @HealthcareBeat
Form S-3 (registration statement under securities act of 1933) filed with the SEC $CBAY https://t.co/5LkdwMBT2H
July 3rd 2020, 12:07pm
HealthcareBeat @HealthcareBeat
CymaBay Therapeutics files for $200M mixed shelf $CBAY https://t.co/4fMX2AkYkH
July 3rd 2020, 4:07am
Tickeron @Tickeron
$CBAY enters a Downtrend as Momentum Indicator dropped below the 0 level on June 29, 2020. View odds for this and o… https://t.co/ouX3JrJQs8
July 3rd 2020, 4:07am
SEC_Filings_Now @SEC_Filings_Now
$CBAY: New SEC Filing for $CBAY: Form S-3 (No. 0001193125-20-186924): https://t.co/46J60mObCt
July 2nd 2020, 9:07pm
AlertTrade @AlertTrade
RT @Briefingcom: $CBAY: CymaBay Therapeutics files for $200 mln mixed securities shelf offering https://t.co/Nuqe8kA6Kc
July 2nd 2020, 8:07pm
Briefingcom @Briefingcom
$CBAY: CymaBay Therapeutics files for $200 mln mixed securities shelf offering https://t.co/Nuqe8kA6Kc
July 2nd 2020, 7:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.